The models are designed to predict someone’s risk of diabetes or stroke. A few might already have been used on patients.
April 14 (Reuters) - OpenAI on Tuesday unveiled GPT-5.4-Cyber, a variant of its latest flagship model fine-tuned specifically ...
An artificial-intelligence revolution in biotechnology won’t get far without human taxonomic expertise — and that’s under ...
A new agentic AI application aims to speed up drug development, helping bring new medical treatments to patients faster.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results